To assess the biological relevance of Notch/HES1 signaling in canine osteosarcoma, probesets including Notch receptor ligands, effectors, or targets of either the canonical Notch pathway or HES1 were selected from Canine 2.0 gene array data and analyzed for differential gene expression as described in materials and methods. This evidence concerns the gene HES1 and osteosarcoma.